|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.995 AUD | +9.62% |
|
+22.77% | +20.54% |
| 07:00am | ASX Biggest Gainers | MT |
| 07-29 | PYC Therapeutics Secures Approval for Higher Dosage in Phase 1b Multiple Ascending Dose Study in Polycystic Kidney Disease | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +9.62% | +22.77% | +28.30% | +65.56% | +20.54% | +64.88% | +243.97% | +24.69% | +1,230.00% | 1.25B | |
| -0.36% | +0.14% | -2.44% | +16.90% | +4.17% | -2.06% | +14.33% | -22.13% | +207.63% | 48.22B | |
| -2.71% | -2.99% | -3.59% | +30.81% | +129.06% | +398.09% | +472.12% | +518.26% | - | 38.79B | |
| -0.71% | +9.45% | +12.71% | +47.91% | +3.53% | +27.90% | +7.89% | -6.65% | +202.91% | 38.41B | |
| -0.71% | -3.72% | +5.42% | +6.78% | +3.28% | +4.94% | +52.45% | -8.11% | +1,080.03% | 34.88B | |
| -2.41% | +1.96% | -0.76% | -4.58% | +5.70% | +11.68% | +38.17% | -16.37% | +153.95% | 29.19B | |
| -0.66% | -2.73% | +2.81% | +37.30% | +2.07% | +35.50% | +122.17% | +224.55% | - | 16B | |
| -0.19% | -3.93% | -11.31% | +10.19% | - | - | - | - | - | 16.05B | |
| -0.62% | +1.23% | -2.34% | +14.77% | +8.56% | +2.76% | +15.05% | -33.78% | +80.78% | 13.53B | |
| -3.15% | -6.14% | -8.47% | +40.37% | -13.07% | -4.82% | -36.90% | -35.10% | +108.76% | 12.22B | |
| +0.07% | +0.73% | +1.85% | +31.12% | +22.67% | +31.43% | -10.95% | -40.04% | +156.16% | 11.24B | |
| -0.71% | +2.93% | +0.08% | +39.26% | +15.74% | +38.32% | +14.55% | -43.86% | +168.58% | 11.12B | |
| +0.94% | -5.21% | -20.52% | +11.25% | -10.88% | +75.33% | +540.98% | +270.00% | +2,491.79% | 10.64B | |
| +0.01% | -0.13% | +0.90% | +66.08% | +77.68% | +255.26% | +534.99% | - | - | 10.07B | |
| -1.98% | -6.96% | +21.98% | +23.06% | +26.87% | +19.83% | +20.23% | -63.11% | - | 8.92B | |
| -3.19% | -2.42% | +0.50% | +34.47% | +51.45% | +145.74% | +612.33% | +168.53% | - | 8.51B | |
| +5.25% | -2.63% | -33.39% | -27.62% | -31.12% | +26.63% | +38.23% | +44.12% | +44.42% | 9.06B | |
| -0.75% | -3.26% | -4.08% | -5.76% | +3.65% | +464.82% | +1,973.22% | +37.43% | - | 8.52B | |
| +2.25% | +3.04% | +5.56% | +23.59% | -10.58% | -19.48% | -18.67% | -27.75% | +37.34% | 8.75B | |
| -2.99% | -8.85% | -11.63% | +24.28% | +28.92% | +133.50% | +320.06% | +67.18% | - | 8.25B | |
| Average | -0.15% | -0.94% | -0.92% | +24.29% | +17.80% | +90.01% | +260.75% | +58.77% | +496.86% | 17.18B | |
| Weighted average by Cap. | -0.87% | -0.37% | -0.61% | +22.31% | +22.31% | +86.25% | +184.58% | +77.46% | +414.91% |
- Stock Market
- Stocks
- PYC Stock
- Sector PYC Therapeutics Limited
Select your edition
All financial news and data tailored to specific country editions
